Skip to main content
Advanced Enzyme Technologies Limited logo

Advanced Enzyme Technologies Limited — Investor Relations & Filings

Ticker · ADVENZYMES ISIN · INE837H01020 LEI · 335800PWJRERMBTUUV90 BSE.NS Manufacturing
Open in API
Filings indexed 938 across all filing types
Latest filing 2024-02-10 Regulatory Filings
Country IN India
Listing BSE.NS ADVENZYMES

About Advanced Enzyme Technologies Limited

https://www.advancedenzymes.com/

Advanced Enzyme Technologies Limited is a research-driven company specializing in the development, manufacturing, and marketing of proprietary enzyme products and probiotics. The company operates across the entire enzyme value chain, from research and development to commercial-scale production. Its diverse portfolio serves multiple sectors, including human nutrition, animal nutrition, and industrial processing. Key applications encompass food and beverage production, dietary supplements, animal feed additives, and various industrial processes such as textiles, detergents, and pulp and paper manufacturing. With a focus on biotechnology and sustainable solutions, the firm leverages its extensive R&D capabilities to provide customized enzyme formulations. The company maintains a global footprint, supplying specialized biological solutions to a broad international client base.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification to stock exchanges about an upcoming conference call to discuss the un-audited financial results for the quarter and nine months ended December 31, 2023. It includes details about the call schedule, participants, and dial-in information. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is an announcement of a conference call event related to financial results, not the transcript or the results report. Therefore, it fits the category of a Call Transcript (CT) announcement, but since it is only an intimation about the call and not the transcript itself, it is best classified as a Regulatory Filing (RNS) as a general regulatory announcement under SEBI regulations.
2024-02-10 English
Acquisition
Regulatory Filings
2024-02-10 English
Outcome of Board Meeting
Regulatory Filings
2024-02-10 English
Financial Result Updates
Regulatory Filings
2024-02-10 English
Board Meeting — ADVANCED ENZYME TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 10-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the…
Regulatory Filings
2024-02-03 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a short notice informing about a scheduled Board Meeting to consider and approve unaudited financial results for a specific quarter and nine months period. It also mentions the closure of the trading window. There is no actual financial data or detailed report content included, only an announcement of the meeting and related procedural information. The document length is only 1447 characters, which is quite short and fits the pattern of an announcement rather than a full report. Therefore, this is an announcement related to Board/Management Information, specifically about a Board Meeting and trading window closure, not the financial results themselves or any other report type.
2024-02-03 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.